GeNeuro SA, a clinical-stage biopharmaceutical company, develops drugs for the treatment of neurodegenerative and autoimmune diseases. The company's lead therapeutic candidate is temelimab, a monoclonal antibody that neutralizes a pathogenic protein of the HERV-W family; treats type 1 diabetes; and treats chronic inflammatory demyelinating polyneuropathy. It also developing GNK301. In addition, It has cooperative research and development agreements with The National Institute of Neurological Disorders and Stroke to develop novel therapeutic antibodies for the treatment of amyotrophic lateral sclerosis; and Academic centers to develop inflammatory psychosis, as well as a research collaboration agreement with International Center for Infectiology Research; and with Northwestern University for human endogenous retrovirus W envelope protein (HERV-W ENV) in long-haul COVID patients. The company was incorporated in 2006 and is headquartered in Plan-les-Ouates, Switzerland.
- -
- -
- -
- -
- -
- -
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
TTM
FRC
- -
- -
- -
- -
- -
- -
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
Revenue per ShareRevenue per Share
- -
- -
- -
- -
- -
- -
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
Basic EPS, GAAPBasic EPS, GAAP
- -
- -
- -
- -
- -
- -
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
Free Cash Flow per Basic ShareFree Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
Dividend per ShareDividend per Share
- -
- -
- -
- -
- -
- -
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
Book Value per ShareBook Value per Share
- -
- -
- -
- -
- -
- -
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
premium
Premium data
Tangible Book Value per ShareTangible Book Value per Share